{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:43:26Z","timestamp":1786221806606,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jns.2026.126096","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:52:39Z","timestamp":1784044359000},"page":"126096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Trends in antiseizure medication use among women of childbearing age with epilepsy"],"prefix":"10.1016","volume":"489","author":[{"given":"Revital","family":"Gandelman-Marton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Theitler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.jns.2026.126096_bb0005","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1212\/WNL.0000000000001487","article-title":"Evidence-based guideline: management of an unprovoked first seizure in adults: report of the guideline development Subcommittee of the American Academy of neurology and the American Epilepsy Society","volume":"84","author":"Krumholz","year":"2015","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.jns.2026.126096_bb0010","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/jama.2022.3880","article-title":"Antiseizure medications for adults with epilepsy: a review","volume":"327","author":"Kanner","year":"2022","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jns.2026.126096_bb0015","doi-asserted-by":"crossref","first-page":"e1031","DOI":"10.1212\/WNL.0000000000006173","article-title":"Unintended pregnancy, prenatal care, newborn outcomes, and breastfeeding in women with epilepsy","volume":"91","author":"Johnson","year":"2018","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jns.2026.126096_bb0020","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/WNL.0000000000003637","article-title":"Predictors of unintended pregnancy in women with epilepsy","volume":"88","author":"Herzog","year":"2017","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jns.2026.126096_bb0025","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1111\/epi.13437","article-title":"Withdrawal of valproic acid treatment during pregnancy and seizure outcome: observations from EURAP","volume":"57","author":"Tomson","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2026.126096_bb0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.seizure.2016.11.007","article-title":"Status epilepticus in pregnant women with epilepsy after valproate adjustment: a case series","volume":"43","author":"Wu","year":"2016","journal-title":"Seizure"},{"issue":"11","key":"10.1016\/j.jns.2026.126096_bb0035","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209279","article-title":"Teratogenesis, perinatal, and neurodevelopmental outcomes after in utero exposure to antiseizure medication: practice guideline from the AAN, AES, and SMFM","volume":"102","author":"Pack","year":"2024","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2026.126096_bb0040","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamaneurol.2024.0258","article-title":"Risk of major congenital malformations and exposure to Antiseizure medication monotherapy","volume":"81","author":"Battino","year":"2024","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.jns.2026.126096_bb0045","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry","volume":"17","author":"Tomson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jns.2026.126096_bb0050","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/01.wnl.0000227919.81208.b2","article-title":"In utero antiepileptic drug exposure: fetal death and malformations","volume":"67","author":"Meador","year":"2006","journal-title":"Neurology"},{"issue":"21","key":"10.1016\/j.jns.2026.126096_bb0055","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hernandez-Diaz","year":"2012","journal-title":"Neurology"},{"issue":"19","key":"10.1016\/j.jns.2026.126096_bb0060","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1001\/jama.2011.624","article-title":"Newer-generation antiepileptic drugs and the risk of major birth defects","volume":"305","author":"M\u00f8lgaard-Nielsen","year":"2011","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jns.2026.126096_bb0065","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","article-title":"Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability","volume":"79","author":"Bj\u00f8rk","year":"2022","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/j.jns.2026.126096_bb0070","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1474-4422(23)00199-0","article-title":"Cognitive outcomes at age 3 years in children with fetal exposure to antiseizure medications (MONEAD study) in the USA: a prospective, observational cohort study","volume":"22","author":"Meador","year":"2023","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jns.2026.126096_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamaneurol.2023.4315","article-title":"Behavioral outcomes and neurodevelopmental disorders among children of women with epilepsy","volume":"81","author":"Cohen","year":"2024","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.jns.2026.126096_bb0080","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1528-1167.2009.02129.x","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.jns.2026.126096_bb0085","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/epi.16953","article-title":"Neurodevelopmental outcomes in children exposed to newer antiseizure medications: a systematic review","volume":"62","author":"Knight","year":"2021","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.jns.2026.126096_bb0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/epi.18180","article-title":"Epilepsy-pregnancy registries: an update","volume":"66","author":"Perucca","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2026.126096_bb0095","author":"WHO"},{"key":"10.1016\/j.jns.2026.126096_bb0100","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/epi.13021","article-title":"Valproate in the treatment of epilepsy in girls and women of childbearing potential","volume":"56","author":"Tomson","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2026.126096_bb0105","unstructured":"www.gov.il\/he\/service\/israeli-drug-index. Accessed 30\/8\/2025. 2026."},{"issue":"4","key":"10.1016\/j.jns.2026.126096_bb0110","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.jns.2026.126096_bb0115","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2026.126096_bb0120","doi-asserted-by":"crossref","DOI":"10.1177\/17562864221101687","article-title":"Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide","volume":"15","author":"Nucera","year":"2022","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jns.2026.126096_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108666","article-title":"Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: a German longitudinal analysis from 2008 to 2020","volume":"130","author":"Hochbaum","year":"2022","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jns.2026.126096_bb0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.seizure.2023.02.015","article-title":"Increasing use of newer antiseizure medication during pregnancy: an observational study with special focus on lacosamide","volume":"107","author":"Hoeltzenbein","year":"2023","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.jns.2026.126096_bb0135","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/bcp.15053","article-title":"Changes in antiepileptic drug prescriptions over a decade in childbearing women in Lombardy region, Italy","volume":"88","author":"Clavenna","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jns.2026.126096_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117500","article-title":"Contemporary trends in antiepileptic drug treatment among women of childbearing age with epilepsy in the United States: 2004-2015","volume":"427","author":"Ajinkya","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.126096_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109091","article-title":"Trends in antiseizure medications utilization among women of childbearing age with epilepsy in Poland between 2015 and 2019","volume":"139","author":"W\u00f3jcik","year":"2023","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jns.2026.126096_bb0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.seizure.2024.01.007","article-title":"Treatment patterns in women of childbearing age and pregnant women with epilepsy in Poland between the years 2019 and 2022-a nationwide population-based cohort study","volume":"115","author":"W\u00f3jcik","year":"2024","journal-title":"Seizure"},{"key":"10.1016\/j.jns.2026.126096_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.109949","article-title":"Trends in prescription of anti-seizure medications in Japan between 2018 and 2021: a retrospective study using the National Database Open Data Japan","volume":"159","author":"Ura","year":"2024","journal-title":"Epilepsy Behav."},{"issue":"10","key":"10.1016\/j.jns.2026.126096_bb0160","doi-asserted-by":"crossref","first-page":"e1083","DOI":"10.1212\/WNL.0000000000207580","article-title":"Utilization of Antiseizure medications in women of childbearing age with epilepsy and nonepilepsy indications: a retrospective cohort study","volume":"101","author":"Lawal","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2026.126096_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109482","article-title":"Changes over 24 years in a pregnancy register - teratogenicity and epileptic seizure control","volume":"148","author":"Vajda","year":"2023","journal-title":"Epilepsy Behav."},{"issue":"1","key":"10.1016\/j.jns.2026.126096_bb0170","doi-asserted-by":"crossref","first-page":"30585","DOI":"10.1038\/s41598-024-83060-9","article-title":"Trends in use of antiseizure medication and treatment pattern during the first trimester in the German Embryotox cohort","volume":"14","author":"Hoeltzenbein","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2026.126096_bb0175","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yebeh.2018.04.009","article-title":"Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy","volume":"84","author":"Meador","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jns.2026.126096_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1469552","article-title":"Trends of antiseizure medication utilization among pregnant people in four Canadian provinces from 1998 to 2023; a study from the Canadian mother-child cohort active surveillance initiative (CAMCCO)","volume":"15","author":"Peymani","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jns.2026.126096_bb0185","article-title":"Twenty-year trends in the use of anti-seizure medication among pregnant women in the Netherlands","volume":"127","author":"Houbem","year":"2022","journal-title":"Epilepsy Behav."},{"issue":"1","key":"10.1016\/j.jns.2026.126096_bb0190","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/1471-0528.17573","article-title":"Trends and patterns of antiseizure medication prescribing during pregnancy between 1995 and 2018 in the United Kingdom: a cohort study","volume":"131","author":"Madley-Dowd","year":"2024","journal-title":"BJOG"},{"key":"10.1016\/j.jns.2026.126096_bb0195","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.seizure.2020.09.008","article-title":"Risk-benefit assessment of treatment of epileptic women of childbearing age with valproic acid","volume":"82","author":"Qu\u00edlez","year":"2020","journal-title":"Seizure"},{"issue":"Pt A","key":"10.1016\/j.jns.2026.126096_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yebeh.2019.06.031","article-title":"Why do some women with epilepsy use valproic acid despite current guidelines? A single-center cohort study","volume":"98","author":"Bosak","year":"2019","journal-title":"Epilepsy Behav."},{"issue":"7","key":"10.1016\/j.jns.2026.126096_bb0205","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jns.2026.126096_bb0210","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ana.26561","article-title":"Comparative safety of Antiseizure medication monotherapy for major malformations","volume":"93","author":"Cohen","year":"2023","journal-title":"Ann. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26003783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26003783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:08:00Z","timestamp":1786219680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26003783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"alternative-id":["S0022510X26003783"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.126096","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in antiseizure medication use among women of childbearing age with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.126096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126096"}}